Medicare Enrolled

Dr. Gincy Samuel, MD

Neurology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
6080 N CENTRAL EXPY STE 100, Dallas, TX 75206
2148273610
In practice since 2007 (18 years)
NPI: 1821298399 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Samuel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Samuel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Samuel

Dr. Gincy Samuel is a neurology in Dallas, TX, with 18 years in practice. Based on federal Medicare data, Dr. Samuel performed 28,293 Medicare services across 628 unique beneficiaries.

Between the years covered by Open Payments, Dr. Samuel received a total of $81,075 from 72 pharmaceutical and/or device companies across 1007 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Samuel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 3% volume in TX$ $81,075 industry payments

Medicare Practice Summary

Medicare Utilization ↗
28,293
Medicare services
Top 3% in TX for neurology
628
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,572 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit18,805$5$20
MRI contrast dye injection (gadoterate)8,610$0$1
Office visit, established patient (30-39 min)421$93$330
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face114$120$435
New patient office visit (45-59 min)61$122$500
Mri scan of brain before and after contrast40$180$1,510
Office visit, established patient, complex (40-54 min)40$131$440
Injection of anesthetic agent and/or steroid into face nerve26$115$540
New patient office visit, complex (60-74 min)25$151$630
Drug injection, under skin or into muscle21$11$80
Office visit, established patient (20-29 min)20$61$225
Mri scan of blood vessels of head without contrast18$87$1,225
Injection of trigger points, 3 or more muscles17$24$195
Injection of anesthetic agent and/or steroid into upper neck and back of head nerve17$38$429
Injection of anesthetic agent and/or steroid into other nerve or branch17$52$321
Mri scan of blood vessels of neck before and after contrast14$222$1,930
Mri scan of upper spinal canal without contrast14$92$975
Measurement of brain wave activity (eeg), awake and drowsy13$308$1,110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$81,075
Total received (2018-2024)
Avg $11,582/year across 7 years
Top 8% in TX for neurology
72
Companies
1,007
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67,972 (83.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,307 (15.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$796 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,249
2023
$11,806
2022
$15,541
2021
$11,746
2020
$29,470
2019
$1,869
2018
$1,393

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$33,091
AbbVie Inc.
$13,120
Allergan, Inc.
$10,280
ABBVIE INC.
$8,724
Biogen, Inc.
$2,233
Lundbeck LLC
$1,819
Genentech USA, Inc.
$914
Sunovion Pharmaceuticals Inc.
$825
UCB, Inc.
$811
Novartis Pharmaceuticals Corporation
$745
Teva Pharmaceuticals USA, Inc.
$680
Amgen Inc.
$621
ARGENX US, INC.
$605
Merz Pharmaceuticals, LLC
$578
Alexion Pharmaceuticals, Inc.
$457
GENZYME CORPORATION
$445
Acorda Therapeutics, Inc
$380
Allergan Inc.
$369
ACADIA Pharmaceuticals Inc
$287
SK Life Science, Inc.
$286
Grifols USA, LLC
$275
Amneal Pharmaceuticals LLC
$274
Upsher-Smith Laboratories LLC
$237
Biohaven Pharmaceutical Holding Company Ltd.
$229
UPSHER-SMITH LABORATORIES LLC
$222
Neurocrine Biosciences, Inc.
$219
Avanir Pharmaceuticals, Inc.
$213
Eisai Inc.
$186
Mitsubishi Tanabe Pharma America, Inc.
$131
PFIZER INC.
$129
MERZ NORTH AMERICA, INC.
$110
Adamas Pharmaceuticals, Inc.
$106
Takeda Pharmaceuticals U.S.A., Inc.
$104
Biohaven Pharmaceuticals, Inc.
$100
Janssen Pharmaceuticals, Inc
$99
Ipsen Biopharmaceuticals, Inc
$90
Horizon Therapeutics plc
$88
Avion Pharmaceuticals
$81
Alnylam Pharmaceuticals Inc.
$80
CSL Behring
$66
TG Therapeutics, Inc.
$65
Kyowa Kirin, Inc.
$52
Merz North America, Inc.
$42
Neurelis, Inc.
$39
TG THERAPEUTICS, INC.
$30
Greenwich Biosciences, Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$28
BANNER LIFE SCIENCES, LLC
$28
Mallinckrodt Enterprises LLC
$28
Octapharma USA, Inc.
$28
Assertio Therapeutics, Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$25
Vanda Pharmaceuticals Inc.
$24
Harmony Biosciences Llc
$24
IMPEL PHARMACEUTICALS INC.
$21
Aucta Pharmaceuticals, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$20
NS Pharma, Inc.
$19
Promius Pharma LLC
$19
Boston Scientific Corporation
$19
Avadel CNS Pharmaceuticals, LLC
$18
Impax Laboratories, Inc.
$18
Scilex Pharmaceuticals Inc.
$18
Avid Radiopharmaceuticals, Inc.
$17
Medtronic USA, Inc.
$17
Almatica Pharma LLC
$15
GE HEALTHCARE
$15
HOSPIRA, INC.
$13
Supernus Pharmaceuticals, Inc.
$13
Collegium Pharmaceutical, Inc.
$12
Bausch Health US, LLC
$11
EMD Serono, Inc.
$11
Top 3 companies account for 69.7% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · CREXONT · Cambia · DAYBUE · DYSPORT · Dhivy · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FABRY-DISEASE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEADPOINT · LEMTRADA · LUMIZYME · LUMRYZ · Leqembi · MIGRANAL · Mavenclad · Motpoly XR · NAPRELAN · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · POMPE - DISEASE · PONVORY · Ponvory · QUDEXY · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · Skyclarys · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VILTEPSO · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · WAKIX · XEOMIN · Xembify · Xeomin · ZEMBRACE SYMTOUCH · ZOMIG · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for neurology in TX.

Equivalent to $287 per 100 Medicare services performed
Looking for a neurology in Dallas?
Compare neurologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
241
Per 100K population
9.3
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
2.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Samuel is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (speaking/promotional, top 8%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Samuel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Samuel performed 18,805 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Samuel receive payments from pharmaceutical companies?
Yes. Dr. Samuel received a total of $81,075 from 72 companies across 1,007 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Samuel's costs compare to other neurologys in Dallas?
Dr. Samuel's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Samuel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →